Horizon, Opiant stock fall on report Elizabeth Warren concerned about pharma deals

Amgen(Applied Molecular Genetics Inc.) Capability Center in Tampa.

JHVEPhoto/iStock Editorial via Getty Images

Horizon Pharmaceuticals (NASDAQ:HZNP) dropped 1.9% on a report that Sen. Elizabeth Warren (D-MA) told the Federal Trade Commission she has concerns about Amgen’s (NASDAQ:AMGN) plan to buy Horizon Therapeutics (HZNP

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!